Neil E. Fleshner Point Biopharma Global Inc. (PNT) insider trading activity

PNT Quotes by TradingView

Neil E. Fleshner is Chief Medical Officer of POINT Biopharma Global Inc.. Currently has a direct ownership of 0 shares of PNT, which is worth approximately $0. The most recent transaction as insider was on Dec 22, 2023, when has been sold 2,773,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

NEIL E. FLESHNER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
2,773,045 Reduced 100.0%
0 Common Stock
Oct 31 2023
SELL
Bona fide gift
-
250,000 Reduced 8.27%
2,773,045 Common Stock
May 25 2022
SELL
Open market or private sale
$4,237,172 $7.51 p/Share
564,204 Reduced 15.73%
3,023,045 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
3,587,249 Added 50.0%
3,587,249 Common Stock
NEF

Neil E. Fleshner

Chief Medical Officer
Indianapolis, IN

Track Institutional and Insider Activities on PNT

Follow POINT Biopharma Global Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PNT shares.

Notify only if

Insider Trading

Get notified when an Point Biopharma Global Inc. insider buys or sells PNT shares.

Notify only if

News

Receive news related to POINT Biopharma Global Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PNT